These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38036191)

  • 1. Mitochondria dysfunction induced by decyl-TPP mitochondriotropic antioxidant based on caffeic acid AntiOxCIN
    Amorim R; Magalhães CC; Benfeito S; Cagide F; Tavares LC; Santos K; Sardão VA; Datta S; Cortopassi GA; Baldeiras I; Jones JG; Borges F; Oliveira PJ; Teixeira J
    Biochem Pharmacol; 2024 Jan; 219():115953. PubMed ID: 38036191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desrisking the Cytotoxicity of a Mitochondriotropic Antioxidant Based on Caffeic Acid by a PEGylated Strategy.
    Fernandes C; Benfeito S; Amorim R; Teixeira J; Oliveira PJ; Remião F; Borges F
    Bioconjug Chem; 2018 Aug; 29(8):2723-2733. PubMed ID: 29965741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN
    Amorim R; Cagide F; Tavares LC; Simões RF; Soares P; Benfeito S; Baldeiras I; Jones JG; Borges F; Oliveira PJ; Teixeira J
    Free Radic Biol Med; 2022 Feb; 179():119-132. PubMed ID: 34954022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria: Targeting mitochondrial reactive oxygen species with mitochondriotropic polyphenolic-based antioxidants.
    Teixeira J; Deus CM; Borges F; Oliveira PJ
    Int J Biochem Cell Biol; 2018 Apr; 97():98-103. PubMed ID: 29454114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases.
    Wu YT; Wu SB; Wei YH
    Curr Pharm Des; 2014; 20(35):5510-26. PubMed ID: 24606797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triphenylphosphonium (TPP)-Based Antioxidants: A New Perspective on Antioxidant Design.
    Wang JY; Li JQ; Xiao YM; Fu B; Qin ZH
    ChemMedChem; 2020 Mar; 15(5):404-410. PubMed ID: 32020724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational discovery and development of a mitochondria-targeted antioxidant based on cinnamic acid scaffold.
    Teixeira J; Soares P; Benfeito S; Gaspar A; Garrido J; Murphy MP; Borges F
    Free Radic Res; 2012 May; 46(5):600-11. PubMed ID: 22292941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the gap between nature and antioxidant setbacks: delivering caffeic acid to mitochondria.
    Teixeira J; Soares P; Benfeito S; Murphy MP; Oliveira PJ; Borges F
    Methods Mol Biol; 2015; 1265():73-83. PubMed ID: 25634268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage.
    Sotolongo K; Ghiso J; Rostagno A
    Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Mitochondriotropic Antioxidant Based on Caffeic Acid: Proof of Concept on Cellular and Mitochondrial Oxidative Stress Models.
    Teixeira J; Cagide F; Benfeito S; Soares P; Garrido J; Baldeiras I; Ribeiro JA; Pereira CM; Silva AF; Andrade PB; Oliveira PJ; Borges F
    J Med Chem; 2017 Aug; 60(16):7084-7098. PubMed ID: 28745898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients.
    Deus CM; Pereira SP; Cunha-Oliveira T; Teixeira J; Simões RF; Cagide F; Benfeito S; Borges F; Raimundo N; Oliveira PJ
    Redox Biol; 2021 Sep; 45():102037. PubMed ID: 34147843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tea polyphenols modulate antioxidant redox system on cisplatin-induced reactive oxygen species generation in a human breast cancer cell.
    Periasamy VS; Alshatwi AA
    Basic Clin Pharmacol Toxicol; 2013 Jun; 112(6):374-84. PubMed ID: 23145928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic triphenylphosphonium derivatives enhance radiation-induced cell killing via inhibition of mitochondrial energy metabolism in tumor cells.
    Yasui H; Yamamoto K; Suzuki M; Sakai Y; Bo T; Nagane M; Nishimura E; Yamamori T; Yamasaki T; Yamada KI; Inanami O
    Cancer Lett; 2017 Apr; 390():160-167. PubMed ID: 28093283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer.
    Wangpaichitr M; Wu C; Li YY; Nguyen DJM; Kandemir H; Shah S; Chen S; Feun LG; Prince JS; Kuo MT; Savaraj N
    Oncotarget; 2017 Jul; 8(30):49275-49292. PubMed ID: 28525376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
    Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
    Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting antioxidants to mitochondria by conjugation to lipophilic cations.
    Murphy MP; Smith RA
    Annu Rev Pharmacol Toxicol; 2007; 47():629-56. PubMed ID: 17014364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.